HNN3.0
Register
Register
Register

Project cooperationUpdated on 25 November 2025

Tackling antibiotic resistance using nano-poly-pharmacology

CEO at THERIOPHARM

Houtain Saint Simeon, Belgium

About

Validated on a sepsis murin model using pan-resistant Acinetobacter baumannii.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Similar opportunities

  • Project cooperation

    AI-Driven Microfluidic 3D In Vitro Platform for Multi-Tissue Crosstalk in Drug Testing

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    MARCO BERZANO

    Research Manager and Advisor - Head of Medical Area at Università Politecnica delle Marche

    Ancona, Italy

  • Project cooperation

    New in vitro assay methodologies

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Hanne Haslene-Hox

    Seinor research scientist at SINTEF Industry

    Trondheim, Norway

  • Project cooperation

    Computer Vision for Stem Cells, Tissues, and Molecular Imaging

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Muhammed Akyuzlu

    AI / Computer Vision Engineering at Emoda

    izmir, Türkiye